Dear Authors,
If you believe that your paper was mistakenly rejected by other leading journals and you do not agree with final decision, the editors of Reports of Practical Oncology and Radiotherapy offer new fast track review. You may submit your manuscript to Reports of Practical Oncology and Radiotherapy together with all prior peer-reviews obtained from the other journal and your rebuttal letter. We guarantee review based decision within 72 hours from the time we will receive your manuscript.

Fast track submission process: Please submit the manuscript with all reviews and rebuttal letter by email to Dr. Michal Masternak ( for fast review processing. To assure immediate attention the email title must to include: RPOR-fast track- Last Name First Name (of corresponding author).

Volume 4, Number 1, 1999

Concurrent chemoradiotherapy in limited-stage small-cell lung cancer. Results of a pilot study

Radkowski A, Korzeniowski S, Sas-Korczyńska B, Małecki K, Skołyszewski J.


Between January 1994 and February 1998, 32 limited-stage small-cell lung cancer patients were treated with concurrent chemoradiotherapy. Follow-up time ranged from 4 to 34 months, (median 14 months). Complete regression was obtained in 22 of tnę 30 patients, who received at least four courses of EP chemotherapy and a tumour dose of 50 Gy or more. In all, 2-year actuarial disease-free survival was 21%. Brain metastases occurred in 8 (36.4%) patients with CR, in 5/7 (71.4%) patients without prophylactic cranial irradiation (PCI) and in 3/15 (20%) patients after PCI. The survival rate was Iower in patients with PCI, in whom chest irradiation was started later than one month from the beginning of course 1 of EP chemotherapy. We have suggested a modification of the treatment protocol.

Signature: Rep Pract Oncol Radiother, 1999; 4(1) : 3-8

« back


Indexed in: EMBASE®, the Excerpta Medica database, the Elsevier BIOBASE (Current Awareness in Biological Sciences) and in the Index Copernicus.